Thromboxane A2 in severe hypertension and stroke in stroke-p…
Established
26
Citations25
Refs1988
Year
Search Works
Work Details
- DOI 10.1161/01.str.19.9.1145
- PMID https://pubmed.ncbi.nlm.nih.gov/3413813
- OpenAlex ID W2077181129
- Type Article
- Language EN
- Published 01 Sep 1988
- Volume 19 (9)
- Pages 1145–1150
- Source Stroke
- Publisher Lippincott Williams & Wilkins
- FWCI 0.64
- Countries 1
- Institutions 1
- Added 24 Jun 2016
- Updated 14 Oct 2026
External Links
MENU
0
Thromboxane A2 in severe hypertension and stroke in stroke-prone spontaneously hypertensive rats.
Article 1988 EN Bronze
Thromboxane A2 is a prostanoid having potent platelet aggregatory and vasoconstrictor properties. To determine a possible role for thromboxane A2 in the development of severe hypertension and stroke, we chronically administered the selective thromboxane A2 synthase inhibitor UK-38,485 (Dazmegrel) to stroke-prone spontaneously hypertensive rats (SHRSP). Serum thromboxane B2 (the stable hydrolysis p…
26
Citations
25
References
3
Authors
0.64
FWCI
Citations by Year
Last 4 yearsTopics
Keywords
UN Sustainable Development Goals
1 SDGsAuthors & Affiliations
3 authors| # | Author | Institutions | ORCID |
|---|---|---|---|
| 1 | Charles T. Stier | New York Medical College (US) | |
| 2 | Ibrahim F. Benter | New York Medical College (US) | |
| 3 | S Levine | New York Medical College (US) | — |
Related Works
10Data: OpenAlex